Press Releases

Press Releases

February 5, 2016
Quanterix announces that is participating in the NFL Health and Safety Update & Interactive Head Health Showcase at Super Bowl 50.
June 15, 2016
Frontage Laboratories, Inc., a Contract Research Organization based in Pennsylvania, New Jersey and China, announces that they are the first CRO to complete a GLP validation of the Simoa HD-1 Analyzer and software along with the interface to Watson LIMS.
January 9. 2017
Amended licensing agreement with long-term partner allows Quanterix to continue innovation and commercialization within its expanding fields
June 22, 2017
CEO and Chairman, Kevin Hrusovsky, will be hosting a webinar on the use of ultrasensitive biomarker assays to enable precision health, with a specialty focus on concussion and traumatic brain injury (TBI) detection and diagnostics.  Hrusovsky will be joined by Dr. Jessica Gill, Investigator at…
Business Wire| November 27, 2017
Quanterix Corporation today announced the commencement of the initial public offering of shares of its common stock pursuant to a registration statement on Form S-1 filed with the Securities and Exchange Commission (the “Commission”).
CAMBRIDGE, MA – May 23, 2010 – Quanterix Corporation, the single molecule diagnostics company focused on developing and commercializing high sensitivity tests, announced the publication of a breakthrough study of the company’s proprietary technology that demonstrates an unprecedented sensitivity…
CAMBRIDGE, MA and SALZBURG, Austria – July 20, 2011 – Quanterix Corporation, enabling a new generation of diagnostic tests based on the revolutionary Single Molecule Array (SiMoA™) technology, and Sony DADC Austria AG, today announced that they have entered into a collaboration for the development…
CAMBRIDGE, MA – December 22, 2011 – Quanterix Corporation, a company enabling a new generation of molecular diagnostic tests based on its revolutionary Single Molecule Array (SiMoA™) technology, has reported a method for detecting individual proteins within microfabricated polymer arrays produced…
LEXINGTON, Mass., January 22, 2013 – Quanterix Corporation announced today that Analytical Chemistry has published a ground-breaking study in which its Simoa technology was used to directly measure bacterial genomic DNA of S. aureus in both human blood and river water at sub-femtomolar…
Lexington, Mass. – February 20, 2014 – Quanterix Corporation, Quanterix Corporation, a leader in high definition diagnostics, delivering ultrasensitive single molecule measurement for the benefit of human health, today announced that it was one of the 33 recipients of the Massachusetts Life…